Since it has been shown that a low plasma activity of APP could be a predisposing factor for the development of angioedema during ACEi treatment [26], in three studies the polymorphism XPNPEP2 of the APP gene was investigated, and a significant association with ACEi-AE was identified consistently in all three studies [18,20,22]. The gene discussed is APP; the disease is angioedema.